10.1080/00397911.2018.1554146
The research aimed to develop new antimicrobial agents by synthesizing and testing benzoxazinoids (BXs) analogs derived from 2-nitrophenol (benzoxazinone series) and 3-hydroxy-2-nitropyridine (pyridoxazinone series). The study employed nucleophilic substitution and reductive cyclization to functionalize these compounds. The synthesized analogs were then tested for their antimicrobial activity against various bacterial and fungal strains. The results showed that the pyridoxazinone series exhibited significant antibacterial activity, particularly against Enterococcus faecalis and Acinetobacter baumannii, with minimum inhibitory concentrations (MICs) ranging from 7.8 to 125 μg/mL. The benzoxazinone series also demonstrated antibacterial activity, though to a lesser extent. In terms of antifungal activity, compound 2e from the pyridoxazinone series was particularly effective against Candida species, with an MIC of 62.5 μg/mL. The study concluded that these BXs analogs have potential as new antimicrobial agents due to their efficacy and low toxicity, as all analogs complied with Lipinski’s rules and were predicted to have low toxicity. The presence of a pyridine ring in the pyridoxazinone series was identified as a key factor enhancing antibacterial activity against Gram-negative bacteria.